A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK
- Status
- COMPLETED
- Phase
- PHASE1
Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY3200882 in Participants With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
ACTolog in Patients With Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
- Status
- COMPLETED
- Phase
- N/A
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
- Status
- TERMINATED
- Phase
- N/A
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
- Status
- RECRUITING
- Phase
- N/A